PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 25 filers reported holding PSYCHEMEDICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $997,069 | -11.6% | 251,151 | +1.5% | 0.00% | – |
Q2 2023 | $1,128,317 | -13.1% | 247,438 | 0.0% | 0.00% | – |
Q1 2023 | $1,299,050 | +7.0% | 247,438 | 0.0% | 0.00% | – |
Q4 2022 | $1,213,609 | -23.9% | 247,438 | +0.0% | 0.00% | – |
Q3 2022 | $1,595,000 | +1.7% | 247,340 | 0.0% | 0.00% | – |
Q2 2022 | $1,568,000 | -8.1% | 247,340 | 0.0% | 0.00% | – |
Q1 2022 | $1,707,000 | -1.7% | 247,340 | 0.0% | 0.00% | – |
Q4 2021 | $1,736,000 | -16.5% | 247,340 | -0.1% | 0.00% | – |
Q3 2021 | $2,080,000 | +20.2% | 247,622 | -0.4% | 0.00% | – |
Q2 2021 | $1,731,000 | +12.3% | 248,700 | 0.0% | 0.00% | – |
Q1 2021 | $1,542,000 | +19.5% | 248,700 | -1.9% | 0.00% | – |
Q4 2020 | $1,290,000 | +15.4% | 253,521 | 0.0% | 0.00% | – |
Q3 2020 | $1,118,000 | -20.6% | 253,521 | 0.0% | 0.00% | – |
Q2 2020 | $1,408,000 | -8.2% | 253,521 | 0.0% | 0.00% | – |
Q1 2020 | $1,534,000 | -33.9% | 253,521 | 0.0% | 0.00% | – |
Q4 2019 | $2,320,000 | +0.4% | 253,521 | 0.0% | 0.00% | – |
Q3 2019 | $2,310,000 | -3.3% | 253,521 | +7.0% | 0.00% | – |
Q2 2019 | $2,390,000 | -23.6% | 236,833 | +6.2% | 0.00% | – |
Q1 2019 | $3,129,000 | -11.0% | 223,031 | +0.7% | 0.00% | – |
Q4 2018 | $3,516,000 | -15.6% | 221,531 | 0.0% | 0.00% | – |
Q3 2018 | $4,167,000 | -2.3% | 221,531 | 0.0% | 0.00% | – |
Q2 2018 | $4,263,000 | -6.9% | 221,531 | 0.0% | 0.00% | – |
Q1 2018 | $4,581,000 | +0.6% | 221,531 | 0.0% | 0.00% | – |
Q4 2017 | $4,555,000 | +12.8% | 221,531 | +1.1% | 0.00% | – |
Q3 2017 | $4,039,000 | -26.1% | 219,169 | 0.0% | 0.00% | – |
Q2 2017 | $5,468,000 | +28.7% | 219,169 | +3.5% | 0.00% | – |
Q1 2017 | $4,247,000 | -18.4% | 211,817 | +0.4% | 0.00% | – |
Q4 2016 | $5,206,000 | +21.1% | 210,917 | -2.6% | 0.00% | – |
Q3 2016 | $4,298,000 | +41.7% | 216,615 | -1.9% | 0.00% | – |
Q2 2016 | $3,033,000 | -10.8% | 220,735 | -10.8% | 0.00% | – |
Q1 2016 | $3,402,000 | +36.4% | 247,395 | +0.5% | 0.00% | – |
Q4 2015 | $2,495,000 | +1.8% | 246,095 | +1.2% | 0.00% | – |
Q3 2015 | $2,450,000 | -31.9% | 243,295 | +0.3% | 0.00% | – |
Q2 2015 | $3,596,000 | -9.7% | 242,507 | +1.1% | 0.00% | – |
Q1 2015 | $3,983,000 | +10.6% | 239,937 | +0.4% | 0.00% | – |
Q4 2014 | $3,601,000 | +5.9% | 238,937 | +0.0% | 0.00% | – |
Q3 2014 | $3,399,000 | +0.5% | 238,837 | 0.0% | 0.00% | – |
Q2 2014 | $3,382,000 | -17.3% | 238,837 | 0.0% | 0.00% | – |
Q1 2014 | $4,091,000 | +17.5% | 238,837 | +0.7% | 0.00% | – |
Q4 2013 | $3,483,000 | +10.9% | 237,102 | 0.0% | 0.00% | – |
Q3 2013 | $3,142,000 | +22.9% | 237,102 | -0.4% | 0.00% | – |
Q2 2013 | $2,557,000 | – | 238,102 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
Cannell Capital | 78,306 | $540,000 | 0.08% |
RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |